The numbers are in!

Thank you to everyone who participated in Fall Advocacy Days and helped make this effort possible. Together, we're building momentum for a future with better treatments, more research, and better outcomes for people affected by kidney cancer.

#AcceleratingCures

Using this information like your diagnosis, treatment history, and location, the Clinical Trial Navigator helps identify clinical trials that may be relevant to your specific circumstances, making it easier to explore your options.

https://kidneycan.org/clinical-trial-navigator/

#AcceleratingCures

Could #KidneyCancer run in your family?

On Oct. 28, our panelists will discuss hereditary kidney cancer, when genetic testing may be considered, and what patients and families should know about inherited risk.

Register: https://kidneycan.org/genetics-kidney-cancer-family-risk

#AcceleratingCures

The American Association for Cancer Research (AACR) Scholar-in-Training Awards will support early-career investigators focused on kidney cancer research.

IMPORTANT: You must apply for AACR Associate Membership by TODAY, October 9, to be eligible!

🔗https://bit.ly/SITA_2026

#AcceleratingCures

Clinical trials may be available at many different points in the #KidneyCancer treatment journey. Exploring what’s available can give you more information to discuss with your healthcare team.

https://kidneycan.org/clinical-trial-navigator/

#AcceleratingCures

Only about 7% of patients with cancer in the U.S. participate in cancer treatment clinical trials.

The Clinical Trial Navigator was created to help identify potential trial matches you can discuss with your healthcare team: https://kidneycan.org/clinical-trial-navigator/

#AcceleratingCures

Could #KidneyCancer run in your family?

Join us October 28 for our FREE Town Hall, Genetics and Kidney Cancer: From Family Risk to the Future of Patient Care.

Register: https://kidneycan.org/genetics-kidney-cancer-family-risk

#AcceleratingCures

This is the 5th IKCC Global Patient Survey, marking 10 years of collecting data specific to the experiences of people living with #KidneyCancer. This milestone makes it possible to track trends and demonstrate changes over time.

https://bit.ly/IKCC_Kidney_Cancer_Global_Survey

#AcceleratingCures

Powered by AI and built specifically for people with #KidneyCancer, the Clinical Trial Navigator helps make complex clinical trial information easier to search and understand.

Explore: https://kidneycan.org/clinical-trial-navigator/

#AcceleratingCures

Join the Judy Nicholson Foundation for Hope in Motion—a FREE day of kidney cancer education for patients & caregivers in Jacksonville, FL, on Oct. 9.

Bring your questions. Hear from experts. Connect with others.

Register: https://jnfkidneycancer.org/jax-symposium/

#AcceleratingCures

Need some direction when it comes to clinical trials?

Meet the KidneyCAN Clinical Trial Navigator—a free, AI-powered tool designed specifically to help people with #KidneyCancer explore trials that may be relevant to them.

🔍 https://kidneycan.org/clinical-trial-navigator/

#AcceleratingCures

Why participate in the Global Patient Survey on #KidneyCancer? The information gathered helps create education, support and advocacy programs that respond to the needs of people affected by kidney cancer.

Take the survey: https://bit.ly/IKCC_Kidney_Cancer_Global_Survey

#AcceleratingCures

Changes are coming to health coverage, and it's important to understand what they could mean for you. TOMORROW, October 1, Triage Cancer is hosting "Understanding Changes to Medicaid & the Marketplace: What Patients and Caregivers Need to Know."

https://triagecancer.org/webinars

#AcceleratingCures

Both clinical and translational research play an important role in advancing our understanding of #KidneyCancer. And the two often work hand in hand. What researchers learn in the lab can help shape clinical studies, while observations from patients can lead to new questions.

#AcceleratingCures

Advocate Andrew Allers is living with stage IV kidney cancer with brain metastases. His piece, Persistence, is a digital composite created from different slices of his own brain MRI. During our advocacy day, he left the piece in the office of his rep, Congressman Jim Himes.

#AcceleratingCures

On World Cancer Research Day, KidneyCAN & the International Kidney Cancer Coalition have launched the Global Patient Survey on Kidney Cancer! All #KidneyCancer patients, carers, & survivors are invited to share their experiences.

https://bit.ly/IKCC_Kidney_Cancer_Global_Survey

#AcceleratingCures

Happy #WorldCancerResearchDay! In #KidneyCancer, research has transformed our understanding of the disease and continues to open new possibilities for diagnosis, treatment, and care. But there is still more to learn and more progress to make.

#AcceleratingCures

We’re excited to announce that the KCRS26 Abstract Supplement has been published in The Oncologist, featuring research presented as part of #KCRS!

Explore the full supplement: https://academic.oup.com/oncolo/issue/31/Supplement_3

#AcceleratingCures

Mark your calendar! The Triage Cancer Health Conference, happening online November 6–7, will cover topics that can make a real difference when navigating a serious or chronic medical condition.

Learn more: https://triagecancer.org/conferences/november-2026

#AcceleratingCures

Today, on Rare Cancer Day, we recognize the people impacted by rare cancers.

Several kidney cancer subtypes are rare, including chromophobe and translocation RCC. Every patient deserves answers. And every person facing a rare cancer deserves a community.

#AcceleratingCures